Emergent BioSolutions (EBS) Enterprise Value (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Enterprise Value of -$161.5 million for Q1 2026, down 5.69% year-over-year from -$171.3 million in Q1 2025, and up 22.76% quarter-over-quarter from -$209.1 million in Q4 2025.
Emergent BioSolutions (EBS) Enterprise Value (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Enterprise Value history runs 17 years deep, the most recent figure standing at -$161.5 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 5.69% year-over-year to -$161.5 million; the TTM figure through Mar 2026 stood at -$161.5 million (down 5.69% YoY), while the FY2025 annual figure was -$209.1 million, down 98.01% from the prior year.
- Enterprise Value for Q1 2026 stood at -$161.5 million, up from -$209.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$71.0 million in Q2 2024, with the low at -$642.6 million in Q4 2022.
- The 5-year median for Enterprise Value is -$161.5 million (2026), against an average of -$226.6 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value jumped 82.62% in 2023, then sank 281.69% in 2025.
- Emergent BioSolutions' Enterprise Value stood at -$642.6 million in 2022, then surged by 82.62% to -$111.7 million in 2023, then grew by 5.46% to -$105.6 million in 2024, then tumbled by 98.01% to -$209.1 million in 2025, then grew by 22.76% to -$161.5 million in 2026.
- Business Quant data shows EBS's Enterprise Value at -$161.5 million in Q1 2026, -$209.1 million in Q4 2025, and -$249.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -140.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -140.90 Mn |
| Mar 31, 2026 | -161.50 Mn |
| Dec 31, 2025 | -209.10 Mn |
| Sep 30, 2025 | -249.20 Mn |
| Jun 30, 2025 | -271.00 Mn |
| Mar 31, 2025 | -152.80 Mn |
| Dec 31, 2024 | -105.60 Mn |
| Sep 30, 2024 | -156.40 Mn |
| Jun 30, 2024 | -71.00 Mn |
| Mar 31, 2024 | -79.00 Mn |
| Dec 31, 2023 | -111.70 Mn |
| Sep 30, 2023 | -87.80 Mn |
| Jun 30, 2023 | -88.60 Mn |
| Mar 31, 2023 | -430.20 Mn |
| Dec 31, 2022 | -642.60 Mn |
| Sep 30, 2022 | -241.00 Mn |
| Jun 30, 2022 | -358.30 Mn |
| Mar 31, 2022 | -436.00 Mn |
| Dec 31, 2021 | -576.30 Mn |
| Sep 30, 2021 | -404.00 Mn |